NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY;LIFE SCIENCE INSTITUTE, INC.
发明人:
Hiroshi SHIMIZU,Yasuyuki FUJITA,Naoya MASUTOMI
申请号：
US16624081
公开号：
US20200206272A1
申请日:
2018.06.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A cell product for treatment of epidermolysis bullosa, comprising a SSEA-3-positive pluripotent stem cell (Muse cell) derived from a mesenchymal tissue in a living body or a cultured mesenchymal cell. Preferably, the epidermolysis bullosa is epidermolysis bullosa simplex, junctional epidermolysis bullosa, or dystrophic epidermolysis bullosa.
